/Abbvie%20Inc%20logo%20and%20meds-%20by%20Ascannio%20via%20Shutterstock.jpg)
North Chicago, Illinois-based AbbVie Inc. (ABBV) focuses on creating medicines and solutions that address complex health issues and enhance people's lives through its core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics, and more. With a market cap of $408.5 billion, AbbVie operates as one of the largest biopharmaceutical companies in the world.
The pharma giant is gearing up to announce its third-quarter results before the market opens on Friday, Oct. 31. Ahead of the event, analysts expect ABBV to report an adjusted profit of $3.25 per share, up 8.3% from $3 per share reported in the year-ago quarter. Further, the company has a robust earnings surprise history. It has surpassed the Street’s bottom-line estimates in each of the past four quarters.
